GlaxoSmithKline

Results: 1417



#Item
991Flovent HFA: Safety Review

Flovent HFA: Safety Review

Add to Reading List

Source URL: www.fda.gov

Language: English
992Rosiglitazone REMS: V.A. Patient Enrollment Form

Rosiglitazone REMS: V.A. Patient Enrollment Form

Add to Reading List

Source URL: www.fda.gov

Language: English
993Augmentin XR  Safety Review

Augmentin XR Safety Review

Add to Reading List

Source URL: www.fda.gov

Language: English
994NBPDP Bulletin 807 February 9, 2011benefit additions.xls

NBPDP Bulletin 807 February 9, 2011benefit additions.xls

Add to Reading List

Source URL: www.gnb.ca

Language: English - Date: 2011-03-03 11:38:40
995MEMORANDUM  DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-13 08:05:24
996Microsoft Word - nonADAPFormulary MAY2009.doc

Microsoft Word - nonADAPFormulary MAY2009.doc

Add to Reading List

Source URL: www.vdh.state.va.us

Language: English - Date: 2013-06-12 10:32:46
997Valacyclovir oral suspension (25 mg/mL or 50 mg/mL) can be prepared from the 500 mg VALTREX Caplets[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VALTREX s

Valacyclovir oral suspension (25 mg/mL or 50 mg/mL) can be prepared from the 500 mg VALTREX Caplets[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VALTREX s

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-04-20 13:49:09
998-------------------------------CONTRAINDICATIONS-----------------------Do not use in patients with history of allergic reaction to any ingredient of RELENZA, including lactose (which contains milk proteins). (4) --------

-------------------------------CONTRAINDICATIONS-----------------------Do not use in patients with history of allergic reaction to any ingredient of RELENZA, including lactose (which contains milk proteins). (4) --------

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-03-26 12:39:13
999HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VERAMYST safely and effectively. See full prescribing information for VERAMYST.  urticaria, may occur after administ

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VERAMYST safely and effectively. See full prescribing information for VERAMYST. urticaria, may occur after administ

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-10-20 14:37:51
1000Fact Sheet: RTS,S Malaria Vaccine Candidate The RTS,S malaria vaccine candidate Malaria kills approximately 900,000 people a year worldwide and sickens tens of millions more, most of them children living in Sub-Saharan A

Fact Sheet: RTS,S Malaria Vaccine Candidate The RTS,S malaria vaccine candidate Malaria kills approximately 900,000 people a year worldwide and sickens tens of millions more, most of them children living in Sub-Saharan A

Add to Reading List

Source URL: malariavaccine.org

Language: English - Date: 2010-04-21 16:09:29